SCHEMBL6046194

SCHEMBL6046194

CCCC=Cc1nnn[nH]1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TYMP P19971 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2088827 0.79
SCHEMBL2091617 0.72 TSHR (0.30)
SCHEMBL2088513 0.71 TSHR (0.31)
SCHEMBL3834178 0.69 TSHR (0.34)
SCHEMBL31674390 0.63 TLR8 (0.31) TYMP
SCHEMBL18867140 0.63 NPC1 (0.39) TYMP
SCHEMBL3405760 0.63 NPC1 (0.39) TYMP
SCHEMBL12997538 0.63 TLR8 (0.31) TYMP
SCHEMBL37295 0.57
SCHEMBL56167 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096837-B Nitride etchant composition and method 恩特格里斯公司 2025-05-13 CN disclosed
CN-118234830-A Selective wet etching composition and method 恩特格里斯公司 2024-06-21 CN disclosed
CN-112236423-B Piperidinyl-3- (aryloxy) propanamides and propionic acid esters 武田药品工业株式会社 2024-02-06 CN disclosed
CN-116761869-A Selective removal of metal oxide hard mask 恩特格里斯公司 2023-09-15 CN disclosed
CN-115485273-A N- (heterocyclyl and heterocyclylalkyl) -3-benzylpyridin-2-amine derivatives as SSTR4 agonists 武田药品工业株式会社 2022-12-16 CN disclosed
CN-115380030-A N-heteroarylalkyl-2- (heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists 武田药品工业株式会社 2022-11-22 CN disclosed
CN-112236423-A Piperidinyl-3- (aryloxy) propanamides and propionates 武田药品工业株式会社 2021-01-15 CN disclosed
US-20060179505-A1 Transgenic mice containing channel activating protease 1 (CAP1) gene disruptions DELTAGEN, INC. 2006-08-10 US disclosed
US-20030167484-A1 Transgenic mice containing channel activating protease 1 (CAP1) gene disruptions DELTAGEN, INC. 2003-09-04 US disclosed
US-4707491-A Anticonvulsant γ-thiobutyrolactone derivatives WASHINGTON UNIVERSITY (US) 1987-11-17 US disclosed